Results 71 to 80 of about 249,854 (357)

Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang, Chengsong Yue, Zhuang Li, Xiaolei Shi, Haoxuan Zhu, Jie Yang, Linyu Li, Jiaxing Song, Shitao Fan, Gaoming Li, Wenzhe Sun, Zhixian Ye, Jiacheng Huang, Dahong Yang, Jinfu Ma, Xu Xu, Zhixi Wang, Lilan Wang, Guojian Liu, Fengli Li, Changwei Guo, Li Qi, Wenjie Zi   +22 more
wiley   +1 more source

Assessment of bleeding during minor oral surgical procedures and extraction in patients on anticoagulant therapy

Journal of Pharmacy and Bioallied Sciences, 2015
Introduction: The risk of postoperative hemorrhage from oral surgical procedures has been a concern in the treatment of patients who are receiving long-term anticoagulation therapy.
S Jimson, Julius Amaldhas, Sudha Jimson, I Kannan, J Parthiban   +4 more
doaj   +1 more source

The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience

Frontiers in Cardiovascular Medicine, 2022
ObjectiveThis study aimed to analyze the characteristics of patients with pericardial effusion requiring pericardiocentesis and to evaluate the safety of pericardiocentesis without discontinuation of anticoagulant or antiplatelet drugs.MethodsWe ...
Yuansong Zhu, Chengxiang Zhang, Yuqiao Xie, Bryan Richard Sasmita, Zhenxian Xiang, Yi Jiang, Ming Gong, Yaxin Wang, Siyu Chen, Suxin Luo, Bi Huang   +10 more
doaj   +1 more source

Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting.

Journal of the American College of Cardiology, 2019
BACKGROUND Complex percutaneous coronary intervention (PCI) is associated with higher ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT).
F. Costa, D. van Klaveren, F. Feres, S. James, L. Räber, T. Pilgrim, M. Hong, Hyo‐Soo Kim, A. Colombo, P. Steg, Deepak L. Bhatt, G. Stone, S. Windecker, E. Steyerberg, M. Valgimigli   +14 more
semanticscholar   +1 more source

Magnetically-controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy-induced Gastrointestinal Injury.

Journal of the American College of Cardiology, 2021
BACKGROUND Gastrointestinal bleeding is the most frequent major complication of antiplatelet therapy. In patients at low bleeding risk, however, clinically overt gastrointestinal bleeding is relatively uncommon.
Yaling Han, Z. Liao, Yi Li, Xianxian Zhao, Shuren Ma, D. Bao, M. Qiu, Jie Deng, Jinhai Wang, Peng Qu, Chunmeng Jiang, S. Jia, Shaoqi Yang, L. Ru, Jianmei Feng, Wei Gao, Yonghui Huang, L. Tao, Ying Han, Kan-Hsiung Yang, Xiaoyan Wang, Wenjuan Zhang, Bangmao Wang, Yue Li, Youlin Yang, Junxia Li, Jiangqiu Sheng, Yi-tong Ma, Min Cui, Sicong Ma, Xiaozeng Wang, Zhaoshen Li, G. Stone   +32 more
semanticscholar   +1 more source

Location‐Specific Hematoma Volume Predicts Early Neurological Deterioration in Supratentorial ICH

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early neurological deterioration (END) adversely affects outcomes in patients with intracerebral hemorrhage (ICH). This study aimed to determine the location‐specific hematoma volumes for END in supratentorial ICH patients. Methods We retrospectively analyzed supratentorial ICH patients presenting from two prospective cohorts.
Zuoqiao Li, Guilin Meng, Zijie Wang, Xiao Hu, Jing Cheng, Chu Chen, Tiannan Yang, Jiaxin Luo, Zizhen Meng, Xueyun Liu, Qi Li   +10 more
wiley   +1 more source

Idiopathic thrombocytopenic purpura: laboratory diagnosis and management

Universa Medicina, 2016
Idiopathic thrombocytopenic purpura (ITP) or immune thrombocytopenic purpura is a disease characterized by low platelet count (
Alvina Alvina
doaj   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Renal artery stenosis-when to screen, what to stent? [PDF]

, 2014
Renal artery stensosis (RAS) continues to be a problem for clinicians, with no clear consensus on how to investigate and assess the clinical significance of stenotic lesions and manage the findings.
A Losito, A Persu, AH Cragg, Alison Severn, Antiplatelet Trialists’ Collaboration, AR Chade, AT Hirsch, B Bruyne De, B Drieghe, B Girolami, BC Jaarsveld van, BH Gray, C Chrysochou, C Chrysochou, C Rountas, CG Missouris, CJ Cooper, CJ Cooper, Claudine G. Jennings, CM Cheung, D Blondin, D Lao, D Mukherjee, DFJ Tollefson, DG Hackam, DP Slovut, DTNA Berg van den, E Balk, FH Messerli, GA McKenzie, GBC Vasbinder, GBC Vasbinder, GJ Williams, H Tan, H Weibull, Isla S. Mackenzie, J Ritchie, J Webster, JL Zhang, John G. Houston, JP Beregi, JV Smit, JW Olin, JW Olin, K Rocha-Singh, K Wheatley, KA Gillis, KJ Hansen, L Bax, L Trinquart, LD Dworkin, LE Ramsay, LM Messina, LU Mailloux, M Seddon, MC Bates, MJ Bloch, MT Caps, MW Burket, OW Kincaid, P Liang, PJ Conlon, PJG Ven van de, PJG Ven van de, Renal Association, S Anand, S Savard, S Willoteaux, Samira Bell, SC Textor, SC Textor, SC Textor, SJ Gandy, SJ Gandy, SM Begelman, SW Lim, T Jonason, Thomas M. MacDonald, TP Murphy, VS Silva, WJ Jean   +80 more
core   +4 more sources

Association of Antiplatelet Therapy, Including Cilostazol, With Improved Survival in Patients With Moyamoya Disease in a Nationwide Study

Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021
Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
W. Seo, Jaeyoung Kim, Eun‐Hyeok Choi, Yesel Kim, Jong-Won Chung, J. Saver, O. Bang, Gyeong-Moon Kim   +7 more
semanticscholar   +1 more source